Natural killer (NK) cells target infected and oncogenic cells, but are difficult to work with in vitro. Discover novel approaches to producing genetically modified NK cells for cell therapy. Natural ...

Building on the success of CAR T cell therapy for treating blood cancers, researchers are developing NK cell therapies that employ the natural ability of these immune cells to eliminate abnormal cells ...

- Proved the excellent anti-tumor efficacy in various solid tumor-bearing animal model SEONGNAM, South Korea--(BUSINESS WIRE)--GICELL announced the data from the preclinical studies on T.O.P. NK ...

NK cells have a crucial role in cancer surveillance and offer a potential avenue for adoptive cell transfer as either mono- or combination immunotherapy. Previous investigations into transferring ...

Bio corporation CHA Biotech is working to secure mass production technology essential for the development and commercialization of CAR-NK therapies that meet global standards. CAR-NK cell therapy is a ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catamaran Bio, Inc., a biotechnology company developing off-the-shelf NK cell therapies to treat cancer, today announced new data demonstrating preclinical efficacy ...